Beta-casein a2 and reducing or preventing symptoms of lactose intolerance
AssigneeThe A2 Milk Company Limited
InventorAndrew John Clarke
Life of this patent
Estimating the term…
Abstract
Preventing or reducing the symptoms of lactose intolerance in an animal comprising the consumption by the animal of a composition containing beta-casein, or providing the composition to the animal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose).
Claims14
-15. (canceled)
A method for preventing or minimizing epigenetic changes to one or more genes responsible for regulating the activity and levels of enzymes involved in digestive processes and gut function in a human, where the method comprises consuming bovine milk or bovine milk product comprising beta-casein, wherein the beta-casein comprises at least 75% by weight of beta-casein variants having proline at position 67 of the beta-casein amino acid sequence.
Dependencies are inferred from the claim text.